7 December 2023
Sidley Advises Underwriters in Pharvaris Offering of Ordinary Shares and Pre-funded Warrants
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Frank Rahmani Lead | Sidley | Partner | Capital Markets, Emerging Companies and Venture Capital | Not stated |
| Sam Gandhi Lead | Sidley | Partner | Capital Markets | Not stated |
| Nicole C. Garrett | Sidley | Associate | Capital Markets | Not stated |
| Kostian Ciko | Sidley | Associate | Capital Markets | Not stated |
| Emily Chazen | Sidley | Associate | Capital Markets | Not stated |
| Tom Duley | Sidley | Partner | Technology and Life Sciences Transactions | Not stated |
| Emily Marden | Sidley | Counsel | Food, Drug and Medical Device | Not stated |
| Eliza Lawless | Sidley | Associate | Food, Drug and Medical Device | Not stated |
Stated terms
- Stated value
- USD 300m (approximately US$300 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Morgan Stanley (Underwriters)
Leerink Partners (Underwriters)